AVROBIO, Inc.

AVRO | $1.205 -2.82% -2.9% 39K

(0.0% 1d) (-4.0% 1m) (27.1% 1y) (-3.2% 2d) (-3.2% 3d) (-4.8% 7d) (8.13% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 54,056,921
http://www.avrobio.com
Sec Filling | Patents | 121 employees

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firms clinical-stage programs include Fabry disease, Gaucher disease and cystinosis . The company was founded by Geoff Mackay in 2015 and is headquartered in Cambridge, MA.

gene therapies treatment

add to watch list Paper trade email alert is off

Press-releases

Trump’s Truth Social company starts trading on Nasdaq with a market value near $6.8 billion after SPAC deal – Fortune
Published: 2024-03-26 (Crawled : 12:00) - spacfeed.com
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -1.64% | O: 2.46% H: 1.6% C: 0.8%
nasdaq company fortune spac deal market

Trump Social Media Firm Soars Ahead of Post-SPAC Deal Debut – Yahoo Finance
Published: 2024-03-26 (Crawled : 11:00) - spacfeed.com
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -1.64% | O: 2.46% H: 1.6% C: 0.8%
media deal

Trump Social Media Firm Soars Ahead of Post-SPAC Deal Debut – Bloomberg
Published: 2024-03-26 (Crawled : 12:30) - spacfeed.com
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -1.64% | O: 2.46% H: 1.6% C: 0.8%
media deal

Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -1.64% | O: 2.46% H: 1.6% C: 0.8%
tx45 group hypertension heart study

S-4/A – AVROBIO, Inc. (0001681087) (Filer)
Published: 2024-03-25 (Crawled : 11:00) - spacfeed.com
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -1.64% | O: 2.46% H: 1.6% C: 0.8%

INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BATL, AVRO, AXNX, JNPR
Published: 2024-02-27 (Crawled : 01:00) - prnewswire.com
JNPR | $36.06 -0.28% 0.06% 4.1M

Technology Services

| -2.75% | O: 0.19% H: 0.3% C: 0.03%
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -7.69% | O: 3.85% H: 0.0% C: -3.7%

Tectonic Therapeutic Announces Participation at Investor Conferences in March
Published: 2024-02-27 (Crawled : 13:00) - biospace.com/
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -7.69% | O: 3.85% H: 0.0% C: -3.7%

S-4 – Atmus Filtration Technologies Inc. (0001921963) (Filer)
Published: 2024-02-14 (Crawled : 14:30) - spacfeed.com
ATMU A | $30.87 -0.71% 0.0% 2M

n/a

| 38.12% | O: -1.21% H: 1.81% C: -0.09%
SCRM S | $10.795 0.23% 0.23% 3.3M

n/a

| 1.5% | O: 0.19% H: 0.0% C: -0.19%
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -7.69% | O: -1.92% H: 1.96% C: 1.18%

S-4 – AVROBIO, Inc. (0001681087) (Filer)
Published: 2024-02-14 (Crawled : 12:00) - spacfeed.com
SCRM S | $10.795 0.23% 0.23% 3.3M

n/a

| 1.5% | O: 0.19% H: 0.0% C: -0.19%
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -7.69% | O: -1.92% H: 1.96% C: 1.18%

S-4 – Powermers Smart Industries, Inc. (0002010682) (Filer)
Published: 2024-02-13 (Crawled : 12:00) - spacfeed.com
SCRM S | $10.795 0.23% 0.23% 3.3M

n/a

| 1.5% | O: 0.19% H: 0.0% C: -0.19%
AVRO | $1.205 -2.82% -2.9% 39K

Health Technology

| -7.69% | O: -1.92% H: 1.96% C: 1.18%
smart

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001127602-24-003481	4	2024-02-06	2024-02-01	Sell	M	37334	111999
0001127602-24-003481	4	2024-02-06	2024-02-05	Sell	F	12232	55872
0001127602-24-003481	4	2024-02-06	2024-02-01	Buy	M	37334	68104